Il y a eu 50 transactions d'initiés récentes enregistrées pour Alumis Inc. Common Stock (ALMS), dont 46 achats et 3 ventes. Le total des achats d'initiés s'élève à $94.64M et le total des ventes d'initiés à RSU Award.
Les initiés notables ayant une activité récente comprennent Tananbaum James B., Foresite Capital Management Vi Llc, Foresite Labs, Llc. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — ALMS
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-04-01 |
Tananbaum James B. |
10 Percent Owner |
Autre (Vente) |
1,123,337 |
- |
- |
- |
| 2026-04-01 |
Foresite Capital Management Vi Llc |
10 Percent Owner |
Autre (Vente) |
1,123,337 |
- |
- |
- |
| 2026-04-01 |
Foresite Labs, Llc |
10 Percent Owner |
Autre (Vente) |
1,123,337 |
- |
- |
- |
| 2026-01-26 |
Babler Martin |
President, CEO and Chairman |
Attribution de RSU |
745,875 |
$26.31 |
$19.62M |
745,875 |
| 2026-01-26 |
Hardiman Roy C. |
Chief Business & Strategy Ofcr |
Attribution de RSU |
190,875 |
$26.31 |
$5.02M |
190,875 |
| 2026-01-26 |
Schroer John R. |
Chief Financial Officer |
Attribution de RSU |
202,225 |
$26.31 |
$5.32M |
202,225 |
| 2026-01-26 |
Goldstein David M |
Chief Scientific Officer |
Attribution de RSU |
216,675 |
$26.31 |
$5.7M |
216,675 |
| 2026-01-26 |
Drappa Jorn |
Chief Medical Officer |
Attribution de RSU |
221,450 |
$26.31 |
$5.83M |
221,450 |
| 2026-01-26 |
Bradley Mark Christopher |
Chief Development Officer |
Attribution de RSU |
190,225 |
$26.31 |
$5M |
190,225 |
| 2026-01-26 |
Pangali Sanam |
Chief Legal Officer |
Attribution de RSU |
186,200 |
$26.31 |
$4.9M |
186,200 |
| 2026-01-09 |
Akkaraju Srinivas |
Director |
Achat Informatif |
588,235 |
$17.00 |
$10M |
1,853,488 |
| 2026-01-08 |
Tananbaum James B. |
10 Percent Owner |
Achat Informatif |
294,117 |
$17.00 |
$5M |
2,908,332 |
| 2026-01-08 |
Foresite Capital Management Vi Llc |
10 Percent Owner |
Achat Informatif |
294,117 |
$17.00 |
$5M |
2,908,332 |
| 2026-01-08 |
Foresite Labs, Llc |
10 Percent Owner |
Achat Informatif |
294,117 |
$17.00 |
$5M |
2,908,332 |
| 2025-12-31 |
Goldstein David M |
Chief Scientific Officer |
Inconnu |
- |
- |
- |
8,994 |
| 2025-12-05 |
Akkaraju Srinivas |
Director |
Achat Informatif |
64,969 |
$8.95 |
$581.47K |
1,143,845 |
| 2025-12-04 |
Akkaraju Srinivas |
Director |
Achat Informatif |
66,027 |
$8.18 |
$540.1K |
1,078,876 |
| 2025-12-03 |
Akkaraju Srinivas |
Director |
Achat Informatif |
100,000 |
$7.75 |
$775K |
1,012,849 |
| 2025-12-02 |
Akkaraju Srinivas |
Director |
Achat Informatif |
96,000 |
$7.55 |
$724.8K |
912,849 |
| 2025-12-01 |
Akkaraju Srinivas |
Director |
Achat Informatif |
86,350 |
$7.46 |
$644.17K |
816,849 |
| 2025-11-28 |
Akkaraju Srinivas |
Director |
Achat Informatif |
38,702 |
$7.64 |
$295.68K |
730,499 |
| 2025-11-26 |
Akkaraju Srinivas |
Director |
Achat Informatif |
48,537 |
$7.64 |
$370.82K |
691,797 |
| 2025-11-21 |
Tananbaum James B. |
10 Percent Owner |
Achat Informatif |
72,212 |
$7.38 |
$532.92K |
2,614,215 |
| 2025-11-21 |
Foresite Capital Management Vi Llc |
10 Percent Owner |
Achat Informatif |
72,212 |
$7.38 |
$532.92K |
2,614,215 |
| 2025-11-21 |
Foresite Labs, Llc |
10 Percent Owner |
Achat Informatif |
72,212 |
$7.38 |
$532.92K |
2,614,215 |
| 2025-11-20 |
Akkaraju Srinivas |
Director |
Achat Informatif |
125,743 |
$7.20 |
$905.35K |
643,260 |
| 2025-11-19 |
Akkaraju Srinivas |
Director |
Achat Informatif |
137,772 |
$6.56 |
$903.78K |
517,517 |
| 2025-11-19 |
Tananbaum James B. |
10 Percent Owner |
Achat Informatif |
190,500 |
$6.56 |
$1.25M |
2,542,003 |
| 2025-11-19 |
Foresite Capital Management Vi Llc |
10 Percent Owner |
Achat Informatif |
190,500 |
$6.56 |
$1.25M |
2,542,003 |
| 2025-11-19 |
Foresite Labs, Llc |
10 Percent Owner |
Achat Informatif |
190,500 |
$6.56 |
$1.25M |
2,542,003 |
| 2025-11-18 |
Akkaraju Srinivas |
Director |
Achat Informatif |
102,652 |
$6.05 |
$621.04K |
379,745 |
| 2025-11-18 |
Tananbaum James B. |
10 Percent Owner |
Achat Informatif |
117,374 |
$6.19 |
$726.55K |
2,351,503 |
| 2025-11-18 |
Foresite Capital Management Vi Llc |
10 Percent Owner |
Achat Informatif |
117,374 |
$6.19 |
$726.55K |
2,351,503 |
| 2025-11-18 |
Foresite Labs, Llc |
10 Percent Owner |
Achat Informatif |
117,374 |
$6.19 |
$726.55K |
2,351,503 |
| 2025-11-17 |
Akkaraju Srinivas |
Director |
Achat Informatif |
914 |
$5.51 |
$5.04K |
277,093 |
| 2025-11-17 |
Tananbaum James B. |
10 Percent Owner |
Achat Informatif |
50,000 |
$5.60 |
$280K |
2,084,129 |
| 2025-11-17 |
Foresite Capital Management Vi Llc |
10 Percent Owner |
Achat Informatif |
50,000 |
$5.60 |
$280K |
2,084,129 |
| 2025-11-17 |
Foresite Labs, Llc |
10 Percent Owner |
Achat Informatif |
50,000 |
$5.60 |
$280K |
2,084,129 |
| 2025-11-13 |
Akkaraju Srinivas |
Director |
Achat Informatif |
276,179 |
$5.25 |
$1.45M |
276,179 |
| 2025-07-30 |
Akkaraju Srinivas |
Director |
Attribution de RSU |
49,800 |
$4.10 |
$204.18K |
49,800 |
| 2025-07-30 |
Machado Patrick |
Director |
Attribution de RSU |
49,800 |
$4.10 |
$204.18K |
49,800 |
| 2025-07-30 |
Yao Zhengbin |
Director |
Attribution de RSU |
49,800 |
$4.10 |
$204.18K |
49,800 |
| 2025-07-30 |
Srivastava Sapna |
Director |
Attribution de RSU |
49,800 |
$4.10 |
$204.18K |
49,800 |
| 2025-07-30 |
Tetrault Lynn A. |
Director |
Attribution de RSU |
49,800 |
$4.10 |
$204.18K |
49,800 |
| 2025-07-29 |
Babler Martin |
President, CEO and Chairman |
Attribution de RSU |
150,000 |
$3.95 |
$592.5K |
150,000 |
| 2025-07-29 |
Hardiman Roy C. |
Chief Business & Strategy Ofcr |
Attribution de RSU |
111,950 |
$3.95 |
$442.2K |
111,950 |
| 2025-07-29 |
Schroer John R. |
Chief Financial Officer |
Attribution de RSU |
28,000 |
- |
- |
28,000 |
| 2025-07-29 |
Goldstein David M |
Chief Scientific Officer |
Attribution de RSU |
27,000 |
- |
- |
29,115 |
| 2025-07-29 |
Drappa Jorn |
Chief Medical Officer |
Attribution de RSU |
25,450 |
- |
- |
28,450 |
| 2025-07-29 |
Richardson Derrick |
SVP, People and Culture |
Attribution de RSU |
42,800 |
- |
- |
42,800 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
